Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 20.5%
Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 20.5%
BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from the June 30th total of 71,800 shares. Based on an average trading volume of 47,100 shares, the days-to-cover ratio is currently 1.2 days.
BetterLife Pharma Price Performance
OTCMKTS BETRF opened at $0.11 on Thursday. The company has a market cap of $5.52 million, a P/E ratio of -0.89 and a beta of 2.90. The stock has a 50-day moving average of $0.09 and a two-hundred day moving average of $0.11. BetterLife Pharma has a 1-year low of $0.05 and a 1-year high of $0.30.
Get BetterLife Pharma alerts:BetterLife Pharma (OTCMKTS:BETRF – Get Rating) last posted its quarterly earnings data on Tuesday, June 28th. The company reported ($0.03) EPS for the quarter.
About BetterLife Pharma
(Get Rating)BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
Further Reading
- Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- PayPal Continues To Struggle As Competition Increases
- Is Starbucks Shooting For The Moon?
- Two High-Yield Deep-Values You Shouldn't Ignore
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from the June 30th total of 71,800 shares. Based on an average trading volume of 47,100 shares, the days-to-cover ratio is currently 1.2 days.
美好生活製藥公司(BetterLife Pharma Inc.)7月份的空頭股數銷量大幅下降。截至7月15日,空頭股數共有57,100股,較6月30日的71,800股下降20.5%。以47,100股的平均成交量計算,目前天數與回補比率為1.2天。
BetterLife Pharma Price Performance
BetterLife Pharma價格表現
OTCMKTS BETRF opened at $0.11 on Thursday. The company has a market cap of $5.52 million, a P/E ratio of -0.89 and a beta of 2.90. The stock has a 50-day moving average of $0.09 and a two-hundred day moving average of $0.11. BetterLife Pharma has a 1-year low of $0.05 and a 1-year high of $0.30.
OTCMKTS BETRF週四開盤報0.11美元。該公司市值552萬美元,市盈率為-0.89,貝塔係數為2.90。該股的50日移動均線切入位在0.09美元,200日移動均線切入位在0.11美元。BetterLife Pharma的一年低點為0.05美元,一年高位為0.30美元。
BetterLife Pharma (OTCMKTS:BETRF – Get Rating) last posted its quarterly earnings data on Tuesday, June 28th. The company reported ($0.03) EPS for the quarter.
BetterLife Pharma(OTCMKTS:BETRF-GET Rating)最近一次公佈季度收益數據是在6月28日(星期二)。該公司公佈了該季度每股收益(0.03美元)。
About BetterLife Pharma
關於BetterLife Pharma
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
BetterLife製藥公司是一家生物技術公司,在加拿大和國際上從事治療神經疾病的化合物的開發和商業化。它參與從一系列基於幹擾素的互補技術中提煉和開發候選藥物,這些技術有可能讓免疫系統參與抗擊病毒感染。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- PayPal Continues To Struggle As Competition Increases
- Is Starbucks Shooting For The Moon?
- Two High-Yield Deep-Values You Shouldn't Ignore
- 免費獲取StockNews.com關於BetterLife Pharma的研究報告(BETRF)
- 有不同類型的股票可供投資
- 是時候開發Molson Coors了,還是啤酒銷售會變得平淡?
- PayPal繼續掙扎,競爭加劇
- 星巴克是在向月球進軍嗎?
- 你不應該忽視的兩個高收益深度價值
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
接受BetterLife Pharma Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對BetterLife Pharma和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧